The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial

10.1186/s13063-017-1808-8

Saved in:

Bibliographic Details
Main Authors:	Young, B, Sadarangani, S, Yew, H.S, Yung, C.F, Leo, Y.S, Chen, M.-C, Wilder-Smith, A
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	2020
Subjects:	diphtheria pertussis tetanus vaccine hemagglutination inhibiting antibody influenza vaccine virus antibody aged antibody titer Article cellular immunity clinical protocol controlled study dosage schedule comparison drug effect drug safety human immune response infection prevention influenza influenza vaccination Influenza virus major clinical study medication compliance nonhuman parallel design patient compliance phase 4 clinical trial randomized controlled trial risk assessment Singapore virus neutralization virus strain age blood clinical trial comparative study drug effects female hemagglutination inhibition test immunization immunology male methodology time factor treatment outcome vaccination vaccine immunogenicity virology Age Factors Aged Antibodies, Viral Clinical Protocols Female Hemagglutination Inhibition Tests Humans Immunity, Cellular Immunization Schedule Immunogenicity, Vaccine Influenza Vaccines Influenza, Human Male Research Design Time Factors Treatment Outcome Vaccination
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/179527
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-179527
record_format	dspace
spelling	sg-nus-scholar.10635-1795272023-08-10T08:36:17Z The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial Young, B Sadarangani, S Yew, H.S Yung, C.F Leo, Y.S Chen, M.-C Wilder-Smith, A SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH diphtheria pertussis tetanus vaccine hemagglutination inhibiting antibody influenza vaccine influenza vaccine virus antibody aged antibody titer Article cellular immunity clinical protocol controlled study dosage schedule comparison drug effect drug safety human immune response infection prevention influenza influenza vaccination Influenza virus major clinical study medication compliance nonhuman parallel design patient compliance phase 4 clinical trial randomized controlled trial risk assessment Singapore virus neutralization virus strain age blood clinical trial comparative study drug effects female hemagglutination inhibition test immunization immunology influenza male methodology time factor treatment outcome vaccination vaccine immunogenicity virology Age Factors Aged Antibodies, Viral Clinical Protocols Female Hemagglutination Inhibition Tests Humans Immunity, Cellular Immunization Schedule Immunogenicity, Vaccine Influenza Vaccines Influenza, Human Male Research Design Singapore Time Factors Treatment Outcome Vaccination 10.1186/s13063-017-1808-8 Trials 18 1 67 2020-10-23T04:52:17Z 2020-10-23T04:52:17Z 2017 Article Young, B, Sadarangani, S, Yew, H.S, Yung, C.F, Leo, Y.S, Chen, M.-C, Wilder-Smith, A (2017). The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial. Trials 18 (1) : 67. ScholarBank@NUS Repository. https://doi.org/10.1186/s13063-017-1808-8 17456215 https://scholarbank.nus.edu.sg/handle/10635/179527 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	diphtheria pertussis tetanus vaccine hemagglutination inhibiting antibody influenza vaccine influenza vaccine virus antibody aged antibody titer Article cellular immunity clinical protocol controlled study dosage schedule comparison drug effect drug safety human immune response infection prevention influenza influenza vaccination Influenza virus major clinical study medication compliance nonhuman parallel design patient compliance phase 4 clinical trial randomized controlled trial risk assessment Singapore virus neutralization virus strain age blood clinical trial comparative study drug effects female hemagglutination inhibition test immunization immunology influenza male methodology time factor treatment outcome vaccination vaccine immunogenicity virology Age Factors Aged Antibodies, Viral Clinical Protocols Female Hemagglutination Inhibition Tests Humans Immunity, Cellular Immunization Schedule Immunogenicity, Vaccine Influenza Vaccines Influenza, Human Male Research Design Singapore Time Factors Treatment Outcome Vaccination
spellingShingle	diphtheria pertussis tetanus vaccine hemagglutination inhibiting antibody influenza vaccine influenza vaccine virus antibody aged antibody titer Article cellular immunity clinical protocol controlled study dosage schedule comparison drug effect drug safety human immune response infection prevention influenza influenza vaccination Influenza virus major clinical study medication compliance nonhuman parallel design patient compliance phase 4 clinical trial randomized controlled trial risk assessment Singapore virus neutralization virus strain age blood clinical trial comparative study drug effects female hemagglutination inhibition test immunization immunology influenza male methodology time factor treatment outcome vaccination vaccine immunogenicity virology Age Factors Aged Antibodies, Viral Clinical Protocols Female Hemagglutination Inhibition Tests Humans Immunity, Cellular Immunization Schedule Immunogenicity, Vaccine Influenza Vaccines Influenza, Human Male Research Design Singapore Time Factors Treatment Outcome Vaccination Young, B Sadarangani, S Yew, H.S Yung, C.F Leo, Y.S Chen, M.-C Wilder-Smith, A The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial
description	10.1186/s13063-017-1808-8
author2	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Young, B Sadarangani, S Yew, H.S Yung, C.F Leo, Y.S Chen, M.-C Wilder-Smith, A
format	Article
author	Young, B Sadarangani, S Yew, H.S Yung, C.F Leo, Y.S Chen, M.-C Wilder-Smith, A
author_sort	Young, B
title	The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial
title_short	The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial
title_full	The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial
title_fullStr	The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial
title_full_unstemmed	The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial
title_sort	immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/179527
_version_	1779152488411168768

The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial

Similar Items